NEW YORK, Jan. 12, 2015 /PRNewswire/ -- Analyst report issued by Small Cap IR. PositiveID Corp. (OTCBB: PSID) is an emerging growth company and developer of biological detection systems that focused on the development of microfluidic systems for the automated preparation of and performance of biological assays in order to detect biological threats at high-value locations, as well as analyze samples in a medical environment. M-BAND (Microfluidic Bio-agent Autonomous Networked Detector) and Firefly Dx are the main proprietaries of PSID.
The Company is nearing initial revenue recognition and the recent first ever issuance of revenue guidance by management. This builds confidence that progress is being made and that we have visibility to deployment. The Company issued revenue guidance through the end of 2015 of $4-10 million (combined between 2014 and 2015), $3.5 million of which is already in backlog. In our view this lowers the risk profile and improves the odds of stock appreciation going forward.
PSID has a number of pieces to the puzzle coming together that position the company as a contender in the BioThreat detection market. The market which is established and in today's world should be generating meaningful revenue for years or decades to come
An analyst brief which covers a brief technical analysis, analyst recommendation and price target can be viewed in its entirety by using the link below. There is no cost obligation required to view this report:
Copy and paste to browser may be required.
About Small Cap IR
An issuer of reports written by chartered financial analysts (CFA's) who provide a straightforward assessment of the profiled company and have pledged to remain free of influence when writing research reports. They include stocks traded in the NYSE, NASDAQ, and OTCBB exchanges.
For more information and services provided beyond this release please use contact information provided below.
This report may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward- looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of mentioned company to be materially different from the statements made herein.
Content is researched, written and reviewed on a best-effort basis by a 3rd party research analyst. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below. We do not engage in high frequency trading.
A full disclaimer can be found by viewing the analyst report.
If you wish to have a company covered in more detail by our team, or wish to learn more about our services, please contact us at [email protected]. For any urgent concerns or inquiries please contact us at [email protected].
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
Contact: [email protected]
SOURCE Small Cap IR